Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Proceedings from symposium on estrogen and dementia

Nov. 21, 1997

Pharmacological effects and pharmacokinetics of Org-21465 in humans

Nov. 21, 1997

Titan and Novartis collaborate on antipsychotic drug

Nov. 21, 1997

CGP-49823 compares favorably to diazepam in rat model of anxiety

Nov. 21, 1997

Bayer seeks FDA approval for metrifonate for Alzheimer's disease

Nov. 21, 1997

Nortran and Bridge Pharma to develop dermal anesthetics

Nov. 20, 1997

Novartis' NK1 antagonist in clinical studies for pain

Nov. 20, 1997

Pharmacological characterization of CCD-3693, an orally available neuroactive steroid

Nov. 20, 1997

Positive preclinical results obtained with Avigen's antiparkinsonian gene therapy

Nov. 20, 1997

New neurologic drugs from Nippon Kayaku

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...